ArrowMark Colorado Holdings LLC Grows Position in Stevanato Group S.p.A. $STVN

ArrowMark Colorado Holdings LLC increased its holdings in Stevanato Group S.p.A. (NYSE:STVN) by 6.7% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,392,581 shares of the company’s stock after buying an additional 86,971 shares during the quarter. ArrowMark Colorado Holdings LLC owned about 0.46% of Stevanato Group worth $35,859,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Artisan Partners Limited Partnership lifted its stake in Stevanato Group by 20.0% during the 2nd quarter. Artisan Partners Limited Partnership now owns 2,733,782 shares of the company’s stock valued at $66,786,000 after acquiring an additional 455,323 shares during the period. Thrivent Financial for Lutherans grew its stake in shares of Stevanato Group by 7.1% in the third quarter. Thrivent Financial for Lutherans now owns 2,372,390 shares of the company’s stock worth $61,089,000 after acquiring an additional 156,733 shares during the period. Bamco Inc. NY raised its holdings in shares of Stevanato Group by 2.1% during the second quarter. Bamco Inc. NY now owns 1,888,050 shares of the company’s stock valued at $46,125,000 after purchasing an additional 39,528 shares during the last quarter. Ranger Investment Management L.P. raised its holdings in shares of Stevanato Group by 125.6% during the second quarter. Ranger Investment Management L.P. now owns 1,321,030 shares of the company’s stock valued at $32,273,000 after purchasing an additional 735,417 shares during the last quarter. Finally, Champlain Investment Partners LLC lifted its position in Stevanato Group by 68.7% during the second quarter. Champlain Investment Partners LLC now owns 1,300,799 shares of the company’s stock valued at $31,779,000 after purchasing an additional 529,950 shares during the period.

Stevanato Group Price Performance

Shares of Stevanato Group stock opened at €15.03 on Friday. The stock’s 50-day simple moving average is €17.06 and its 200-day simple moving average is €21.40. Stevanato Group S.p.A. has a 52 week low of €13.91 and a 52 week high of €28.00. The company has a market capitalization of $4.55 billion, a price-to-earnings ratio of 25.92, a PEG ratio of 1.34 and a beta of 0.57. The company has a quick ratio of 1.26, a current ratio of 1.76 and a debt-to-equity ratio of 0.23.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on STVN shares. Weiss Ratings cut shares of Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday. KeyCorp lowered their price target on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, March 5th. Wall Street Zen downgraded Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Jefferies Financial Group set a $17.50 price objective on Stevanato Group in a report on Tuesday, February 10th. Finally, Morgan Stanley reduced their price objective on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, March 6th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Stevanato Group presently has a consensus rating of “Moderate Buy”.

Stevanato Group Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.